Document:

Exhibit 10.1

 

EMPLOYMENT AGREEMENT

This amended and
restated Employment Agreement (this “Agreement”) by and between Unico American Corporation (“Company”)
and Cary L. Cheldin (“Executive”) is effective as of March 17, 2015, and is entered into based on the following facts:

A.The Company
is engaged in the business of insurance and related operations. The Executive will primarily perform the job duties at 23251 Mulholland
Drive, Woodland Hills, California or at 26050 Mureau Road, Calabasas, California.

B.The Company
desires to have the continued services of the Executive.

C.The Executive
is willing to remain employed by Company.

Therefore, the parties
agree as follows:

1.                 
EMPLOYMENT. The Company shall continue to employ the Executive as President & Chief Executive Officer
of the Company. The Executive shall provide to the Company the following services: Duties as needed including day to day management
of the Company and its subsidiaries; and serve as President, Vice President or other officer of all Company subsidiaries, as reasonably
required by the Company. The Executive accepts and agrees to such continued employment, and agrees that he is subject to the general
supervision, advice, and reasonable direction of the Company’s Board of Directors. This Employment Agreement amends and restates
all existing prior Employment Agreements between the Company and the Executive.

2.                 
BEST EFFORTS OF THE EXECUTIVE. The Executive agrees to perform faithfully, industriously, and to the best
of the Executive’s ability, experience, and talents, all of the duties that may reasonably be required by the terms of this
Agreement. Under no circumstances shall the Executive be obligated without his consent to relocate his residence in order to render
the services or, except for occasional business trips, to perform his duties outside of the Woodland Hills/Calabasas, California
area.

3.                 
COMPENSATION OF THE EXECUTIVE.

3.1             
Salary. As compensation for the services provided by the Executive under this Agreement, the Company will pay the
Executive an annual salary of no less than $315,000 (the “Base Salary”) payable in accordance with the Company’s
usual payroll procedures. The Base Salary shall be subject to increase from time to time at the discretion of the Board of Directors
of Company.

3.2             
Bonus. The Company shall pay to the Executive a bonus (the “Mandatory Bonus”) on or before December 31
of each year. The amount of the Mandatory Bonus shall be in an amount determined by the Board of Directors, in its discretion,
but shall not be less than $54,000, less any amounts paid to the Executive as a discretionary bonus since the immediately preceding
January 1.

Nothing herein shall
prevent the Board of Directors from electing, in its discretion, to grant a discretionary bonus to the Executive, in addition to
the Mandatory Bonus and in such amount as the Board of Directors determines.

3.3             
Upon Termination On Account Of The Executive’s Death, By The Company For Cause Or On Account Of The Executive’s
Disability, Or By The Executive Other Than For Breach By The Company. Upon termination of this Agreement on account of the
Executive’s death, by the Company for Cause or on account of the Executive’s disability, or by the Executive other
than for a breach of this Agreement by the Company, payments under this Section 3 shall cease; provided, however, that the Executive
(or his estate in the event of his death) shall be entitled to payments of accrued but unpaid salary and other compensation for
periods or partial periods that occurred prior to the date of termination and any unreimbursed business expenses (throughout this
Agreement referred to as “Accrued Payments”).

3.4             
Upon Termination Without Cause or Breach by The Company. Upon termination of this Agreement by the Company without
Cause or by the Executive on account of a breach of this Agreement by the Company, the Company shall pay to the Executive immediately
any Accrued Payments and pay to the Executive during such calendar year the Mandatory Bonus for such calendar year to the extent
not previously paid, without giving effect to his termination of employment, paid as and when provided herein. In addition, provided
that the Executive executes a general release in the form attached as Exhibit A within 30 days of the termination of his employment
and does not in the seven days thereafter revoke such general release, the Company shall (a) pay the Executive in a single lump
sum three times his then-current Base Salary within 45 days of the Executive’s termination of employment, without discount
or mitigation (if such 45 day period spans two calendar years, the lump sum shall be paid in the second calendar year), (b) pay
the Executive the minimum Mandatory Bonus of $54,000 for the three calendar years following his termination of employment, without
giving effect to his termination of employment, paid as and when provided herein, and (c) provide the Executive with his benefits
as described in Section 5 for the three years following his termination of employment (without giving effect to the termination),
or if the Company cannot provide such benefits, the cash equivalent to reimburse Executive for the cost (including any tax cost)
to purchase same in the open market with such reimbursements to be made monthly for such three-year period. Notwithstanding the
foregoing, to the extent any of the amounts under clause (b) can be paid to Executive at the same time as the amounts under clause
(a) without violating Section 409A, they shall instead be paid at such time.

3.5             
Accrued Vacation. The Company will pay accrued but unpaid vacation in accordance with the laws of the State of California
and the Company’s customary procedures, including on termination of employment.

3.6             
Limitation On Payments. Notwithstanding the foregoing, in the event that it is determined that the aggregate value
of payment or distribution by the Company to the Executive pursuant to this Agreement whether paid or payable (a “Payment”)
constitutes an “excess parachute payment” as defined in Section 280G(b) of the Internal Revenue Code of 1986, as amended
(the “Code”) subject to the excise tax imposed under Section 4999 of the Code (the “Excise Tax”), the aggregate
present value of the Payment shall be reduced to an amount expressed in a present value without causing any Payment to be subject
to the limitation of deduction under Section 280G of the Code. In the event any portion of the amounts payable is reduced pursuant
to this Section 3.6, any cash payments shall be reduced first in the reverse order of when they would be paid, followed by any
benefits described in Section 5 in the reverse order of when they would be paid or provided, followed by any equity benefits, unless
this order of reduction would result in adverse tax consequences under Section 409A of the Code (“Section 409A”) in
which case the Payments shall be reduced in such order as may be required to avoid adverse tax consequences under Section 409A.
All determinations made pursuant to this Section 3.6 shall be made by an independent accounting firm of the Company’s choice,
in their reasonable discretion and in consultation with the Executive’s accountant(s).

3.7             
Compliance with Section 409A. Notwithstanding any other provision of this Agreement, to the extent that (a) any payment
pursuant to this Agreement is treated as nonqualified deferred compensation pursuant to Section 409A and (b) the Executive is a
“specified employee” pursuant to Section 409A (2) (B) of the Code, then the amount of such payment that is payable
to the Executive during the first 6 months following the Executive’s termination of employment shall not exceed the lesser
of (i) 2 times the Executive’s salary or (ii) 2 times the maximum amount that may be taken into account under a qualified
plan pursuant to Section 401(a)(17) of the Code for the year in which such termination occurred, to the extent that payment of
such amounts would not result in adverse tax consequences under Section 409A. Except for the amounts described in the preceding
sentence, any amount otherwise due and payable to the Executive during the first six months after the Executive’s termination
of employment shall be paid as soon as administratively practicable following the 6-month anniversary of the Executive’s
termination of employment, but in no event later than the next regularly scheduled payroll period following such 6 month anniversary,
in accordance with the Company’s typical payroll practices. Each payment hereunder is designated as a separate payment for
purposes of Section 409A. The term “termination of employment” and similar phrases when used in this Agreement refer
to the Executive’s “separation from service” from the Company within the meaning of Section 409A

4.                 
EXPENSE REIMBURSEMENT. The Company will promptly reimburse the Executive for “out-of-pocket”
expenses incurred by the Executive in accordance with the Company’s policies in effect from time to time. Provided, however,
that all such reimbursements shall be made no later than the end of the calendar year following the calendar year in which such
expenses were incurred and this sentence shall not permit the Company to delay reimbursement.

5.                 
BENEFITS. The Executive shall be entitled to employment benefits, including holidays, personal leave,
sick leave, vacation, health insurance, disability insurance, life insurance, and pension plan as provided by the Company’s
policies in effect from time to time. These benefits shall cease upon the effective date of termination of employment provided
that this Agreement is terminated by the Company for Cause or by the Executive for other than a breach of this Agreement by the
Company. Notwithstanding the foregoing, disability insurance shall be an amount sufficient to provide compensation to the Executive,
if disabled, equal to 70% of the compensation that the Executive would be entitled pursuant to Sections 3.1. Further, during the
term of this Agreement, the benefits hereunder shall not be reduced from those provided to the Executive as of December 15, 2007.

6.                 
TERM/TERMINATION. The Executive’s employment under this Agreement shall continue until terminated
by (a) the Executive’s death, (b) the Company without Cause on thirty days’ advance written notice, (c) the Executive
other than for breach of this Agreement on thirty days’ advance written notice, (d) the Executive for a material breach by
the Company of the terms of this Agreement, which is not cured within thirty (30) days after the Executive provides the Company
written notice describing such breach with particularity, (e) the Company for Cause (as defined in Section 7), or (f) the Company
on account of the Executive’s permanent disability pursuant to Section 8.

7.                 
CAUSE OR BREACH BY THE COMPANY. The term “Cause” as used in this Agreement shall mean (a)
chronic alcoholism or drug addiction, (b) material fraud in connection with the Executive’s duties to the Company, (c) unlawful
and intentional material misappropriation of any money or other assets or properties of the Company or any affiliate of the Company,
(d) a material breach by the Executive of the terms of this Agreement which is not cured within thirty (30) days after the Company
has given the Executive written notice describing such material breach with particularity, (e) the conviction of the Executive
of any felony or other serious crime involving moral turpitude, (f) the Executive’s gross moral turpitude relevant to his
office or employment with the Company or any affiliate of the Company, and (g) the Executive’s willful engagement in misconduct
which is demonstrably and materially injurious to the Company and its subsidiaries taken as a whole. No act, or failure to act,
on the part of the Executive shall be considered “willful” unless done, or omitted to be done, by the Executive not
in good faith and without a reasonable belief that the action or omission was in the best interests of the Company or its subsidiaries.

8.                 
TERMINATION FOR DISABILITY. The Company shall have the option to terminate this Agreement, if the Executive
becomes permanently disabled and is no longer able to perform the essential functions of his position with reasonable accommodation,
provided that the Company has provided the disability insurance benefit described in Section 5. The Company shall exercise this
option by giving sixty days prior written notice of such termination to the Executive. A termination of this Agreement pursuant
to this Section 8 shall not be a termination by the Company of this Agreement without Cause.

9.                 
INDEMNIFICATION. To the fullest extent permitted under the law, the Company shall indemnify the Executive,
if the Executive is made a party, or threatened to be made a party, to any threatened, pending, or contemplated action, suit, or
proceeding, whether civil, criminal, administrative, or investigative, by reason of the fact that the Executive is or was an employee,
officer or director of the Company or any affiliate of the Company, in which capacity the Executive is or was serving the Company,
against any and all liabilities, costs, expenses (including reasonable attorneys’ fees and costs), judgments, fines, and
amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit, or proceeding. In the
case of any claim, the Company shall advance reasonable costs of defense (including reasonable attorneys’ fees) provided
that the Executive agrees to repay such advances if it is finally determined that the Executive was not entitled to indemnification
with respect to such claim. This Section shall not limit in any way the Executive’s rights under any agreement relating specifically
to indemnification or under applicable law. This section shall survive the termination or expiration of this Agreement.

10.             
CONFIDENTIALITY. The Executive recognizes that he has and will have information regarding matters such
as trade secrets, customer lists, product design, and other vital information (collectively, “Information”) which are
valuable, special, and unique assets of the Company. The Executive agrees that he will not at any time or in any manner, either
directly or indirectly, divulge, disclose, or communicate in any manner any Information to any third party without the prior written
consent of the Company (which consent may not be signed by the Executive on the Company’s behalf. The Executive will protect
the Information and treat it as strictly confidential. A violation by the Executive of this paragraph shall be a material breach
of this Agreement and will justify legal and/or equitable relief. This section shall survive the termination or expiration of this
Agreement.

11.             
RETURN OF PROPERTY. Upon termination of his employment, or at any other time on the Board’s reasonable
advance written request, the Executive shall deliver to the Company all of the Company’s property (including keys, records,
notes, data, memoranda, models, and equipment) that is in the Executive’s possession or under the Executive’s control.
Such obligation is governed by any separate confidentiality or proprietary rights agreement signed by the Executive. This section
shall survive the termination or expiration of this Agreement.

12.             
NOTICES. All notices required or permitted under this Agreement shall be in writing and shall be deemed
delivered when delivered in person or on the third day after being deposited in the United States mail, postage paid, addressed
as follows:

The Company:

Unico American Corporation

Attention: Secretary

23251 Mulholland Drive

Woodland Hills, California 91364

Executive:

Cary L. Cheldin

23251 Mulholland Drive

Woodland Hills, California 91364

Either party may
change such addresses from time to time by providing written notice in the manner set forth above.

13.             
ENTIRE AGREEMENT.  This Agreement contains the entire agreement of the parties with respect to the subject
matter hereof and there are no other promises or conditions in any other agreement whether oral or written with respect to the
subject matter hereof.

14.             
AMENDMENT. This Agreement may be modified or amended, if the amendment is in writing and signed by both
parties.

15.             
SEVERABILITY. If any provision of this Agreement is found by a court or arbitrator invalid or unenforceable
for any reason, the remaining provisions shall continue to be valid and enforceable. If a court finds that any provision of this
Agreement is invalid or unenforceable, but that by limiting such provision it would become valid or enforceable, then such provision
shall be deemed to be written, construed, and enforced as so limited.

16.             
WAIVER OF CONTRACTUAL RIGHT. The failure of either party to enforce any provision of this Agreement shall
not be construed as a waiver or limitation of that party’s right to subsequently enforce and compel strict compliance with
every provision of this Agreement.

17.             
COUNTERPARTS. This Agreement may be executed in two or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument.

18.             
HEADINGS. The headings in the Agreement are for reference purposes only and shall not in any way affect
the meaning or interpretation of this Agreement.

19.             
APPLICABLE LAW. To the extent not governed by U.S. federal law, the laws of the State of California shall
govern this Agreement without giving effect to its choice of laws provisions.

20.             
COSTS OF LITIGATION & INTEREST. The prevailing party in any arbitration or litigation relating to
this Agreement will be entitled to recover his or its reasonable expenses, costs, and fees (including attorneys’ fees and
costs). The Company shall pay to Executive interest at the rate of 10% per annum (or the highest permissible rate under applicable
law, if less) on all amounts due under this Agreement that are not timely paid.

COMPANY:

Unico American Corporation

Date: March 18, 2015      By:
/s/ Lester A. Aaron

Secretary,
Treasurer and Chief Financial Officer

EXECUTIVE:

Date: March 18, 2015      By:
/s/ Cary L. Cheldin

       

     

    	 

    	 

    

 

EXHIBIT A

SETTLEMENT AGREEMENT

In order to settle
as fully as possible all known and unknown claims I, Cary L. Cheldin, might have against Unico American Corporation (Company) and
all related parties, the Company and I agree as follows:

(a)              
Consideration: The Company will pay and provide me
the amounts and benefits described in Section 3.4 of that certain Employment Agreement between me and the Company, dated March
17, 2015 (the “Employment Agreement”) at the times described in Section 3.4 of the Employment Agreement, less required
payroll deductions.

(b)              
Release: I release all known and unknown claims that
I presently have against the Company, all current and former, direct and indirect parents, subsidiaries, brother-sister companies,
and all other affiliates and related partnerships, joint ventures, or other entities, and, with respect to each of them, their
predecessors and successors; and, with respect to each such entity, all of its past, present, and future employees, officers, directors,
stockholders, owners, representatives, assigns, attorneys, agents, insurers, employee benefit programs (and the trustees, administrators,
fiduciaries, and insurers of such programs), and any other persons acting by, through, under or in concert with any of the persons
or entities listed in this section, and their successors (Released Parties). For example, I am releasing all common law contract,
tort, or other claims I might have, as well as all claims I might have under the Age Discrimination in Employment Act (ADEA), Title
VII of the Civil Rights Act of 1964, Sections 1981 and 1983 of the Civil Rights Act of 1866, the Americans With Disabilities Act
(ADA), the Employee Retirement Income Security Act of 1974 (ERISA), and any similar domestic or foreign laws, such as the California
Fair Employment and Housing Act, California Labor Code Section 200 et seq., and any applicable California Industrial Welfare Commission
order.

I expressly waive
the protection of Section 1542 of the Civil Code of the State of California, which states that:

A general release does not extend
to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which
if known by him or her must have materially affected his or her settlement with the debtor.

Notwithstanding the foregoing, this
Agreement does not release any claims that cannot be released as a matter of law, any rights to vested benefits I may have (e.g.,
under the Company’s 401(k) plan), any claims or rights I may have as an officer or shareholder of the Company, any right
to indemnification I may have, or any rights I have under this Agreement or any continuing rights I have under my Employment Agreement.

(c)               
Applicable Law: This Agreement is governed by Federal
law and the laws of California, without giving effect to its choice of laws provisions.

(d)              
Representations and Promises: The Company and I acknowledge
and agree that: 

                                             
(i)                  
Complete Agreement: This Agreement is the entire agreement relating to any claims or
future rights that I might have with respect to the Company and the Released Parties. Once in effect, this Agreement is a legally
admissible and binding agreement. It shall not be construed strictly for or against the Company or me.

                                           
(ii)                  
Amendments: This Agreement only may be amended by a written agreement that the Company
and I both sign.

                                         
(iii)                  
Representations: When I decided to sign this Agreement, I was not relying on any representations
that are not in this Agreement. The Company would not have agreed to pay the consideration I am getting in exchange for this Agreement
but for the representations and promises I am making by signing it. I have not suffered any job-related wrongs or injuries, such
as any type of discrimination, for which I might still be entitled to compensation or relief now or in the future.

                                         
(iv)                  
Reemployment: I promise not to seek employment with the Company or any Released Party
unless it asks me to do so in writing.

                                           
(v)                  
No Wrongdoing: This Agreement is not an admission of wrongdoing by me, the Company
or any other Released Party; neither it nor any drafts shall be admissible evidence of wrongdoing.

                                         
(vi)                  
Unknown Claims: I am intentionally releasing claims that I do not know that I might
have and that, with hindsight, I might regret having released. I have not assigned or given away any of the claims I am releasing.

                                       
(vii)                  
Effect of Void Provision: If the Company or I successfully assert that any provision
in this Agreement is void, the rest of the Agreement shall remain valid and enforceable unless the other party to this Agreement
elects to cancel it. If this Agreement is cancelled, I will repay the consideration I received for signing it.

                                     
(viii)                  
Consideration of Agreement: If I initially did not think any representation I am making
in this Agreement was true or if I initially was uncomfortable making it, I resolved all my doubts and concerns before signing
this Agreement. I have carefully read this Agreement, I fully understand what it means, I am entering into it knowingly and voluntarily,
and all my representations in it are true. The consideration period described in the box above my signature started when I first
was given this Agreement, and I waive any right to have it restarted or extended by any subsequent changes to this Agreement. 

                                         
(ix)                  
Return of Company Property: I have returned to the Company all of the Company’s
and its subsidiaries’ property, including their files, memoranda, documents, records, copies of the foregoing, Company-provided
credit cards, keys, building passes, security passes, access or identification cards. I agree not to incur any expenses, obligations,
or liabilities on behalf of the Company.

                                     
(x)                  
Employment Termination: My Company employment terminated before I signed this Agreement. 

YOU MAY NOT MAKE ANY CHANGES TO THE
TERMS OF THIS AGREEMENT. BEFORE SIGNING THIS AGREEMENT, READ IT CAREFULLY, AND THE COMPANY SUGGESTS THAT YOU DISCUSS IT WITH YOUR
ATTORNEY AT YOUR OWN EXPENSE. TAKE AS MUCH TIME AS YOU NEED TO CONSIDER THIS AGREEMENT BEFORE DECIDING WHETHER TO SIGN IT, UP TO
21 DAYS. BY SIGNING IT YOU WILL BE WAIVING YOUR KNOWN AND UNKNOWN CLAIMS.

 THIRTY DAYS AFTER THE TERMINATION
OF YOUR EMPLOYMENT IS THE DEADLINE FOR YOU TO DELIVER A SIGNED COPY OF THIS AGREEMENT TO THE COMPANY’S SECRETARY AT
THE COMPANY’S CORPORATE HEADQUARTERS. IF YOU FAIL TO DO SO, YOU WILL NOT RECEIVE THE SPECIAL PAYMENTS OR BENEFITS DESCRIBED
IN IT.

YOU MAY REVOKE THIS AGREEMENT
IF YOU REGRET HAVING SIGNED IT. TO DO SO, YOU MUST DELIVER A WRITTEN NOTICE OF REVOCATION TO THE COMPANY’S SECRETARY AT
THE COMPANY’S CORPORATE HEADQUARTERS BEFORE SEVEN 24-HOUR PERIODS EXPIRE FROM THE TIME YOU SIGNED IT. IF YOU REVOKE THIS
AGREEMENT, IT WILL NOT GO INTO EFFECT AND YOU WILL NOT RECEIVE THE SPECIAL PAYMENTS OR BENEFITS DESCRIBED IN IT. 

 

Date:  _______________        _________________________

 Cary L. Cheldin

 

 

Date: _______________        __________________________ 

Unico American Corporation

This Agreement need not be signed by the Company to be effective.ex10-33.htm

Exhibit 10.33

 

SECOND AMENDMENT TO CREDIT AGREEMENT

 

THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of March 19, 2015, is entered into by and among VARIATION BIOTECHNOLOGIES (US), INC., a Delaware corporation (the “Borrower”); VBI Vaccines Inc., a Delaware corporation (“Holdco”); Variation Biotechnologies, Inc., a corporation incorporated under the Canada Business Corporation Company (“Canadian Sub” and together with Holdco, the “Guarantors”); and PCOF 1, LLC (the “Lender”). Terms used herein without definition shall have the meanings ascribed to them in the Credit Agreement defined below.

 

RECITALS

 

A.     The Borrower, the Lender and the Guarantors have previously entered into that certain Credit Agreement, dated as of July 24, 2014, as amended pursuant to that certain First Amendment to Credit Agreement, dated as of September 30, 2014 (as may be further amended, modified and supplemented from time to time, the “Credit Agreement”), pursuant to which the Lender has made certain loans and financial accommodations available to Borrower.

 

B.     The Borrower and the Lenders wish modify certain provisions of the Credit Agreement on the terms and conditions set forth herein.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1.     Amendment to Credit Agreement.

 

(a)     Section 7.18 of the Credit Agreement is deleted in its entirety and replaced with the following:

 

Required Milestones. Holdco and the Borrower covenant and agree that (i) on or before April 30, 2015 the Borrower will have entered into a licensing agreement with a global pharmaceuticals company with respect to the Thermostable LPV technology, on terms satisfactory to the Lender, (ii) on or before September 25, 2015 the Borrower will have commenced toxicology work with respect to the CMV (VLP) Product, in the form of a first immunization of an animal for GLP toxicology, and (iii) on or before April 25, 2016 the Borrower will have commenced Phase I clinical trials with respect to the CMV (VLP) Product, in the form of a patient vaccination.

 

2.     Acknowledgement of Assignment. Borrower acknowledges that all obligations under the Credit Agreement have been assigned by the Lender, pursuant to the terms of the Credit Agreement, to Perceptive Credit Opportunities Fund, LP, a related entity, which going forward has agreed to operate as though it were a named party therein acting as Lender.

 

3.     Effective of this Amendment. Except as amended and set forth above, the Credit Agreement shall continue in effect in accordance with its terms without modification.

 

 

 

 

 

4.     Choice of Law. The validity of this Amendment, the construction, interpretation, and enforcement hereof, and the rights of the parties hereto with respect to all matters arising hereunder or related hereto shall be determined under, governed by, and construed in accordance with the law of the State of New York.

 

5.     Counterparts. This Amendment may be executed in any number of counterparts and by different parties and separate counterparts, each of which when so executed and delivered, shall be deemed an original, and all of which, when taken together, shall constitute one and the same instrument. Delivery of an executed counterpart of a signature page to this Amendment by facsimile, pdf or other similar method of electronic transmission shall be effective as delivery of a manually executed counterpart of this Amendment.

 

6.     Entire Agreement. This Amendment, together with the Credit Agreement, and all exhibits and schedules attached hereto and thereto, constitute the entire agreement among the parties hereto pertaining to the subject matter hereof or thereof, and any and all other written or oral agreements existing among the parties hereto are expressly cancelled.

 

 

 

 

[Signature pages follow.]

 

 

 

 

 

IN WITNESS WHEREOF, the parties have entered into this Amendment as of the date first above written.

 

	
 

VARIATION BIOTECHNOLOGIES (US), INC.,

as the Borrower

	  
	
By: /s/ Jeff Baxter                                                     

	
Name: Jeff Baxter

	
Title: Chief Executive Officer

	
 

 

 

VBI VACCINES INC.,

as Guarantor

	  
	
By: /s/ Jeff Baxter                                                      

	
Name: : Jeff Baxter

	
Title: Chief Executive Officer

	
 

 

VARIATION BIOTECHNOLOGIES, INC.,

as Guarantor

	  
	
By: /s/ Jeff Baxter                                                      

	
Name: Jeff Baxter
Title: Chief Executive Officer

 

 

[Signature Page to VBI – Perceptive Second Amendment to Credit Agreement]

 

 

 

 

 

 

	
Perceptive Credit Opportunities Fund, LP,
as the Lender

 

By: Perceptive Credit Opportunities GP, its general partner

	  
	
By: /s/ Sandeep Dixit                                                                  

	
Name: Sandeep Dixit
Title: Chief Credit Officer

	
 

By: /s/ James Mannix                                                                  

	
Name: James Mannix
Title: Chief Operating Officer

 

 

[Signature Page to VBI – Perceptive Second Amendment to Credit Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}]]